Suppr超能文献

Sweet综合征作为胆囊腺癌的首发表现

Sweet's syndrome as the presenting manifestation of gall bladder adenocarcinoma.

作者信息

Jindal Rashmi, Jain Anshu, Mittal Ankur, Shirazi Nadia

机构信息

Department of Dermatology, Himalayan Institute Hospital Trust, Dehradun, Uttaranchal, India.

出版信息

BMJ Case Rep. 2012 Oct 12;2012:bcr2012006869. doi: 10.1136/bcr-2012-006869.

Abstract

Sweet's syndrome is a neutrophilic inflammatory dermatosis presenting with sudden onset tender red to purple papules and nodules, fever and neutrophilia. Gastrointestinal and urinary tract infections, pregnancy, inflammatory bowel disease, drugs and malignancy are some of the known aetiological factors. Paraneoplastic Sweet's syndrome accounts for 15-20% cases and thus forms an important subset. At times its onset helps in suspecting an underlying malignancy, thus making timely intervention possible. In the present case report Sweet's syndrome was the presenting feature of gall bladder adenocarcinoma; an association that has been rarely reported before.

摘要

斯威特综合征是一种嗜中性粒细胞性炎症性皮肤病,表现为突发的、触痛的红色至紫色丘疹和结节、发热及嗜中性粒细胞增多。胃肠道和尿路感染、妊娠、炎症性肠病、药物及恶性肿瘤是一些已知的病因。副肿瘤性斯威特综合征占病例的15% - 20%,因此构成一个重要的亚组。有时其发病有助于怀疑潜在的恶性肿瘤,从而使及时干预成为可能。在本病例报告中,斯威特综合征是胆囊腺癌的首发特征;这种关联此前鲜有报道。

相似文献

1
Sweet's syndrome as the presenting manifestation of gall bladder adenocarcinoma.
BMJ Case Rep. 2012 Oct 12;2012:bcr2012006869. doi: 10.1136/bcr-2012-006869.
2
Sweet's syndrome and malignancy in the U.K.
Br J Dermatol. 1997 Oct;137(4):609-13. doi: 10.1111/j.1365-2133.1997.tb03796.x.
4
Sweet's syndrome triggered by pneumococcal vaccination.
Cutan Ocul Toxicol. 2013 Sep;32(3):260-1. doi: 10.3109/15569527.2012.759960. Epub 2013 Jan 25.
5
Serum cytokine profile in pediatric Sweet's syndrome: a case report.
J Med Case Rep. 2017 Jul 2;11(1):178. doi: 10.1186/s13256-017-1317-0.
6
Paraneoplastic Sweet's syndrome.
An Bras Dermatol. 2018 Jul-Aug;93(4):576-578. doi: 10.1590/abd1806-4841.20187353.
8
Acute febrile neutrophilic dermatosis (Sweet's syndrome) in a patient with biliary sepsis.
Postgrad Med J. 2013 Dec;89(1058):731-2. doi: 10.1136/postgradmedj-2013-132162. Epub 2013 Sep 18.
9
Insight into Sweet's syndrome and associated-malignancy: a review of the current literature.
Int J Oncol. 2013 May;42(5):1516-22. doi: 10.3892/ijo.2013.1874. Epub 2013 Mar 28.

引用本文的文献

1
Paraneoplastic Syndromes in Gallbladder Cancer: A Systematic Review.
Medicina (Kaunas). 2025 Feb 27;61(3):417. doi: 10.3390/medicina61030417.
2
The Broad Spectrum of Gallbladder Paraneoplastic Syndromes.
Gastro Hep Adv. 2023 Dec 22;3(5):565-572. doi: 10.1016/j.gastha.2023.12.005. eCollection 2024.
3
Insights Into the Pathogenesis of Sweet's Syndrome.
Front Immunol. 2019 Mar 12;10:414. doi: 10.3389/fimmu.2019.00414. eCollection 2019.

本文引用的文献

3
Efficacy of anakinra, an IL1 receptor antagonist, in refractory Sweet syndrome.
Ann Rheum Dis. 2008 Feb;67(2):278-9. doi: 10.1136/ard.2006.068254.
4
Sweet's syndrome: a spectrum of unusual clinical presentations and associations.
Br J Dermatol. 2007 Mar;156(3):480-5. doi: 10.1111/j.1365-2133.2006.07677.x.
5
Bullous variant of Sweet's syndrome.
Int J Dermatol. 2005 Nov;44(11):946-7. doi: 10.1111/j.1365-4632.2004.02287.x.
6
Drug-induced Sweet's syndrome.
J Eur Acad Dermatol Venereol. 2004 Mar;18(2):233. doi: 10.1111/j.1468-3083.2004.00866.x.
7
AN ACUTE FEBRILE NEUTROPHILIC DERMATOSIS.
Br J Dermatol. 1964 Aug-Sep;76:349-56. doi: 10.1111/j.1365-2133.1964.tb14541.x.
8
Neutrophilic dermatoses: an overview.
Clin Dermatol. 2000 May-Jun;18(3):229-31. doi: 10.1016/s0738-081x(99)00115-7.
9
[Sweet syndrome: practical conduct].
Ann Dermatol Venereol. 1999 Apr;126(4):343-7.
10
Sweet's syndrome secondary to granulocyte colony-stimulating factor.
J Am Acad Dermatol. 1996 Dec;35(6):995-7. doi: 10.1016/s0190-9622(96)90132-2.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验